GLYCINOROM TOLAL 30 10 S

About

GLYCINOROM TOLAL 30 contains Gliclazide 30mg, a sulfonylurea antidiabetic agent used in the management of type 2 diabetes mellitus. Gliclazide primarily works by stimulating the beta cells of the pancreas to release more insulin, particularly in the presence of glucose. This action helps to lower blood glucose levels. It binds to specific receptors on pancreatic beta cells, leading to depolarization and subsequent calcium influx, which triggers insulin secretion. The modified-release formulation ensures a sustained release of the drug, providing consistent glycemic control throughout the day.

This medication is prescribed when diet, exercise, and weight reduction alone are insufficient to control blood glucose levels in adults with type 2 diabetes. It is important to note that Gliclazide requires some residual pancreatic beta-cell function to be effective. Regular monitoring of blood glucose levels is essential to optimize treatment and minimize the risk of hypoglycemia, a common side effect associated with sulfonylureas.

Uses

• Treatment of type 2 diabetes mellitus
• Lowering of blood glucose levels
• Stimulation of insulin secretion
• Adjunct to diet and exercise

Directions For Use

Take one tablet orally once daily with breakfast, as directed by your doctor. Swallow the tablet whole; do not crush or chew.

Benefits

• Effective in lowering blood sugar
• Sustained release for once-daily dosing
• Helps improve pancreatic beta-cell function
• Reduces HbA1c levels
• Well-established efficacy
• May have some antioxidant properties

Side Effects

• Hypoglycemia (low blood sugar)
• Weight gain
• Gastrointestinal disturbances (nausea, diarrhea)
• Abdominal pain
• Headache
• Dizziness
• Skin rash
• Pruritus (itching)
• Urticaria (hives)
• Elevated liver enzymes (rare)
• Blood dyscrasias (rare)
• Allergic reactions

Safety Measures

• Alcohol - Avoid alcohol consumption as it can increase the risk of hypoglycemia and may cause a disulfiram-like reaction in some individuals.
• Pregnancy - Not recommended during pregnancy. Insulin therapy is generally preferred for glycemic control in pregnant women with diabetes.
• Breastfeeding - Not recommended during breastfeeding as Gliclazide may pass into breast milk and cause hypoglycemia in the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustment may be necessary due to altered metabolism and increased risk of hypoglycemia.
• Kidney - Use with caution in patients with kidney impairment; dose adjustment may be necessary to avoid drug accumulation and increased risk of hypoglycemia.
• Lung - Generally not a primary concern for lung conditions. However, severe respiratory conditions might indirectly affect glucose metabolism.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.